4 Jun 2015 07:00
4 June 2015
NMC HEALTH PLC ANNOUNCES APPOINTMENT OF J.P. MORGAN CAZENOVE AS JOINT CORPORATE BROKER
NMC Health plc (LSE:NMC) ('NMC'), the leading integrated private sector healthcare operator in the United Arab Emirates and one of the top global providers of fertility treatments through its Spanish subsidiary Clinica Eugin, is pleased to announce the appointment of J.P. Morgan Cazenove as Joint Corporate Broker alongside HSBC.
Enquiries:
NMC Health plc
Prasanth Manghat, Deputy Chief Executive Officer+971 (0)50 522 5648
Roy Cherry, Head of Strategy & Investor Relations+971 (0)50 667 0184
Media:
FTI Consulting, London
Matthew Cole
+44 (0)20 3727 1101
FTI Consulting, Gulf
Shane Dolan
+971 (0)4 437 2100
About NMC
NMC Health plc group is the leading private sector healthcare operator in the United Arab Emirates, with a nation-wide network of hospitals and operations in the country since 1975. The Healthcare Division currently operates or manages seven hospitals, two day-care patient centres, nine medical centres and fifteen pharmacies. In addition, the Group owns and operates Clinica Eugin in Barcelona, Spain - one of the leading fertility treatment centres globally. The enlarged company received almost 2.8m patients in 2014.The group also operates a significant UAE wide Distribution business supplying product lines across several key market segments, including: Pharmaceutical, FMCG, Food and Scientific and Medical Equipment. NMC Health plc group reported revenues of US$ 644m in 2014.
In April 2012 NMC Health plc was listed on the Premium Segment of the London Stock Exchange. At the time of its IPO, the group raised funds to enable it to pursue a further growth plan with a number of capital projects for new healthcare facilities in Abu Dhabi and Dubai. NMC Health plc is a constituent of the FTSE 250 Index.